Impact of Elexacaftor-Tezacaftor-Ivacaftor on lung disease in cystic fibrosis.

Gushue, Courtney; Eisner, Mariah; Bai, Shasha; Johnson, Terri; Holtzlander, Melissa; McCoy, Karen; Sheikh, Shahid

Gushue, Courtney; Eisner, Mariah; Bai, Shasha; Johnson, Terri; Holtzlander, Melissa; McCoy, Karen; Sheikh, Shahid.

Afiliación

Gushue C; Departments of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, USA.
Eisner M; Division of Pulmonary Medicine, The Ohio State University College of Medicine, Columbus, Ohio, USA.
Bai S; Nationwide Children's Hospital, Columbus, Ohio, USA.
Johnson T; Nationwide Children's Hospital, Columbus, Ohio, USA.
Holtzlander M; Biostatistics Resource, The Ohio State University College of Medicine, Columbus, Ohio, USA.
McCoy K; Biostatistics Resource, The Ohio State University College of Medicine, Columbus, Ohio, USA.
Sheikh S; Departments of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, USA.

Pediatr Pulmonol ; 58(8): 2308-2316, 2023 Aug.

Article en En | MEDLINE | ID: mdl-37222417

Asunto(s)

Fibrosis Quística; Masculino; Humanos; Femenino; Fibrosis Quística/complicaciones; Fibrosis Quística/tratamiento farmacológico; Pirazoles; Regulador de Conductancia de Transmembrana de Fibrosis Quística/genética; Aminofenoles/uso terapéutico; Mutación; Benzodioxoles/uso terapéutico

Palabras clave

bronchiectasis; chest computed tomography; cystic fibrosis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibrosis Quística Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Pediatr Pulmonol Asunto de la revista: PEDIATRIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google